MIRM Research and Charts

MIRM - Mirum Pharmaceuticals Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2026-02-03 (Delayed quote data 2026-02-10)

Last 100.91	Change ⇑ +0.37 (+0.37%)	Volume 254,239
	Open 100.54	High 101.26	Low 99.82

8EMA (Daily) 100.81	40EMA (Daily) 90.28	50EMA (Daily) 87.85	STO (Daily) 68.808	MACD Hist (Daily) -1.128
8EMA (Weekly) 92.828	40EMA (Weekly) 72.04	50EMA (Weekly) 68.31	STO (Weekly) 91.706	MACD Hist (Weekly) 2.414


Company Profile
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.